MD:
Thanks for your comments. We will have to agree to disagree. Please note that current equipment for IVF is highly reliable and works well for LN temps. This is supported by large numbers of IVF procedures conducted annually and a significant number of high quality suppliers to the industry.
I don't understand your observation about Irvine Scientific (Fuji) looking into the potential. Since they already sell various sample tubes it makes sense to me that they would want be looking to differentiate their products from others, similar to Labcon. The question is if a new product will move the needle in terms of increased market share. Please elaborate your thoughts.
Do I understand the last paragraph that expanding presence in the IVF area will serve as a gateway to other sectors? Please comment.
IMO the most significant opportunity for BCT is still for biorepositories. Efforts in this area are making good progress based on company reports.
- Forums
- ASX - By Stock
- BCT
- Ann: Open Briefing
Ann: Open Briefing, page-57
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BCT (ASX) to my watchlist
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.91M |
Open | High | Low | Value | Volume |
0.4¢ | 0.5¢ | 0.4¢ | $3.271K | 697.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 125000 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 1821815 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 125000 | 0.004 |
15 | 4255665 | 0.003 |
9 | 4290024 | 0.002 |
3 | 5300000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 1816815 | 7 |
0.006 | 3774670 | 8 |
0.007 | 1358539 | 4 |
0.008 | 363476 | 1 |
0.009 | 690000 | 2 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
BCT (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online